The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Adicet Bio, Inc. | COM | 007002108 | 998,653 | 728,944 | SH | DFND | 1 | 0 | 728,944 | 0 | ||
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 2,637,491 | 394,834 | SH | DFND | 1 | 0 | 394,834 | 0 | ||
Apollomics, Inc. | CL A SHS | G0411D107 | 49,629 | 13,252 | SH | DFND | 1 | 0 | 13,252 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | 6,652,958 | 247,598 | SH | DFND | 1 | 0 | 247,598 | 0 | ||
BiomX Inc. | COM | 09090D103 | 750,958 | 2,133,402 | SH | DFND | 1 | 0 | 2,133,402 | 0 | ||
Catalyst Biosciences, Inc. | COM | 14888D208 | 32,290 | 66,951 | SH | DFND | 1 | 0 | 66,951 | 0 | ||
Clearside Biomedical, Inc. | COM | 185063104 | 147,560 | 169,629 | SH | DFND | 1 | 0 | 169,629 | 0 | ||
Cue Health, Inc. | COM | 229790100 | 2,454,263 | 5,548,864 | SH | DFND | 1 | 0 | 5,548,864 | 0 | ||
CVRx, Inc. | COM | 126638105 | 53,027,873 | 3,495,575 | SH | DFND | 1 | 0 | 3,495,575 | 0 | ||
Fate Therapeutics, Inc. | COM | 31189P102 | 7,163,616 | 3,379,064 | SH | DFND | 1 | 0 | 3,379,064 | 0 | ||
Fusion Pharmaceuticals Inc. | COM | 36118A100 | 9,543,342 | 3,670,516 | SH | DFND | 1 | 0 | 3,670,516 | 0 | ||
Legend Biotech Corporation | ADS | 52490G102 | 54,715,742 | 814,586 | SH | DFND | 1 | 0 | 814,586 | 0 | ||
MeiraGTx Holdings plc | COM | G59665102 | 32,607,624 | 6,641,064 | SH | DFND | 1 | 0 | 6,641,064 | 0 | ||
Nano-X Imaging Ltd. | ORD SHS | M70700105 | 2,084,138 | 317,704 | SH | DFND | 1 | 0 | 317,704 | 0 | ||
Nanobiotix S.A. | SPONSORED ADS | 63009J107 | 8,396,824 | 959,637 | SH | DFND | 1 | 0 | 959,637 | 0 | ||
Neumora Therapeutics, Inc. | COM | 640979100 | 12,870,126 | 912,128 | SH | DFND | 1 | 0 | 912,128 | 0 | ||
Point Biopharma Global Inc. | COM | 730541109 | 6,670,000 | 1,000,000 | SH | DFND | 1 | 0 | 1,000,000 | 0 | ||
Procept BioRobotics Corporation | COM | 74276L105 | 11,743,979 | 357,939 | SH | DFND | 1 | 0 | 357,939 | 0 | ||
Protagonist Therapeutics Inc. | COM | 74366E102 | 40,852,372 | 2,449,183 | SH | DFND | 1 | 0 | 2,449,183 | 0 | ||
Senseonics Holdings, Inc. | COM | 81727U105 | 32,986 | 54,621 | SH | DFND | 1 | 0 | 54,621 | 0 | ||
Tracon Pharmaceuticals, Inc. | COM | 89237H209 | 14,953 | 84,003 | SH | DFND | 1 | 0 | 84,003 | 0 | ||
Vor Biopharma, Inc. | COM | 929033108 | 2,278,275 | 1,074,658 | SH | DFND | 1 | 0 | 1,074,658 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 15,073,449 | 748,062 | SH | DFND | 1 | 0 | 748,062 | 0 | ||
SomaLogic, Inc. | COM | 83444K105 | 671,714 | 281,052 | SH | DFND | 0 | 281,052 | 0 |